mrd-edge-detection-agent

<!--

COPYRIGHT NOTICE

This file is part of the "Universal Biomedical Skills" project.

Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>

All Rights Reserved.

#

This code is proprietary and confidential.

Unauthorized copying of this file, via any medium is strictly prohibited.

#

Provenance: Authenticated by MD BABU MIA

-->

---

name: 'mrd-edge-detection-agent'

description: 'Ultra-sensitive AI-powered molecular residual disease detection using MRD-EDGE deep learning for sub-0.001% VAF ctDNA detection and early relapse prediction.'

measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.

allowed-tools:

• read_file
• run_shell_command

---

MRD-EDGE Detection Agent

The MRD-EDGE Detection Agent implements the MRD-EDGE (Enhanced Detection of ctDNA through Genomic Error suppression) deep learning algorithm for ultra-sensitive molecular residual disease detection. This AI-powered approach achieves unprecedented sensitivity in predicting cancer recurrence, detecting ctDNA at levels below 0.001% VAF with zero false negatives in validation studies.

When to Use This Skill

• When standard ctDNA assays show negative but MRD is suspected.
• For ultra-sensitive post-surgical MRD monitoring.
• To detect relapse at the earliest possible timepoint.
• When monitoring therapy response in minimal disease settings.
• For research studies requiring highest sensitivity MRD detection.

Core Capabilities

1. Ultra-Sensitive Detection: Detect ctDNA at 0.0001-0.001% VAF levels.

1. Deep Learning Error Suppression: AI-powered sequencing error filtering.

1. Integrated Noise Modeling: Patient-specific background noise estimation.

1. Multi-Feature Integration: Combine mutations, fragmentation, methylation.

1. Zero False Negative Design: Optimized for sensitivity while controlling specificity.

1. Longitudinal Tracking: Monitor MRD over time with confidence intervals.

MRD-EDGE Algorithm Components

| Component | Function | Improvement |

|-----------|----------|-------------|

| Error Suppression Network | Deep learning noise filter | 10x sensitivity |

| Duplex Consensus | UMI-based error correction | 100x error reduction |

| Fragment Analysis | Tumor fragment enrichment | 2-3x signal boost |

| Integration Model | Multi-feature Bayesian fusion | Improved accuracy |

Sensitivity Comparison

| Method | LOD (VAF) | False Negative Rate |

|--------|-----------|---------------------|

| Standard NGS | 1% | High |

| UMI-corrected | 0.1% | Moderate |

| Tumor-informed panels | 0.01% | Low |

| MRD-EDGE | 0.001% | Near-zero |

Workflow

1. Input: Deep sequenced cfDNA (>30,000x), tumor WES, matched normal.

1. Preprocessing: UMI deduplication, duplex consensus, quality filtering.

1. Noise Modeling: Patient-specific error profile estimation.

1. Feature Extraction: Mutations, fragments, methylation signals.

1. Deep Learning Inference: MRD-EDGE neural network prediction.

1. Bayesian Integration: Combine features with uncertainty.

1. Output: MRD probability, detected variants, confidence intervals.

Example Usage

User: "Run MRD-EDGE analysis on this post-surgical colorectal cancer patient's plasma sample."

Agent Action:

python3 Skills/Oncology/MRD_EDGE_Detection_Agent/mrd_edge_detect.py \
    --cfdna_bam plasma_cfDNA.bam \
    --tumor_vcf primary_tumor_mutations.vcf \
    --normal_bam matched_normal.bam \
    --coverage_depth 50000 \
    --cancer_type colorectal \
    --model_weights mrd_edge_v2.pt \
    --output mrd_edge_results/

Input Requirements

| Input | Requirement | Purpose |

|-------|-------------|---------|

| cfDNA BAM | >30,000x depth, UMI-tagged | ctDNA detection |

| Tumor VCF | WES/WGS mutations | Tumor-informed tracking |

| Normal BAM | Matched germline | Background subtraction |

| Coverage Depth | Minimum 30,000x | Sensitivity threshold |

Output Components

| Output | Description | Format |

|--------|-------------|--------|

| MRD Probability | 0-1 probability of MRD | .json |

| MRD Call | Positive/Negative with CI | .json |

| Detected Variants | Variants contributing to call | .vcf |

| Feature Scores | Per-feature contributions | .csv |

| Noise Profile | Patient error model | .json |

| Visualization | MRD landscape plot | .png |

Deep Learning Architecture

| Layer | Function | Parameters |

|-------|----------|------------|

| Variant Encoder | Per-variant feature extraction | 2M |

| Attention Layer | Cross-variant relationships | 1M |

| Noise Classifier | Error vs true mutation | 5M |

| Integration Head | Multi-feature fusion | 2M |

| Output Layer | MRD probability | 100K |

Feature Categories

| Category | Features | Weight |

|----------|----------|--------|

| Mutation Signal | VAF, read count, strand bias | Primary |

| Fragment Features | Size, end motifs, coverage | Secondary |

| Sequence Context | Trinucleotide, mappability | Noise correction |

| Patient Background | Germline, CHIP, noise | Specificity |

Clinical Validation

| Study | Cancer Type | Sensitivity | Specificity | Lead Time |

|-------|-------------|-------------|-------------|-----------|

| CRC Validation | Colorectal | 100% (5/5) | 95% | 10 months |

| Lung Validation | NSCLC | 95% | 92% | 6 months |

| Breast Validation | Breast | 93% | 94% | 12 months |

AI/ML Components

Error Suppression Network:

• Convolutional layers for sequence context
• Recurrent layers for read-level features
• Attention for cross-read patterns

Bayesian Integration:

• Prior from tumor mutational burden
• Likelihood from detected signals
• Posterior probability of MRD

Training Strategy:

• Semi-supervised with spike-in controls
• Hard negative mining from CHIP
• Transfer learning across cancer types

Prerequisites

• Python 3.10+
• PyTorch 2.0+
• UMI-tools, fgbio for UMI processing
• bcftools, samtools
• MRD-EDGE model weights
• High-memory compute (>64GB RAM)
• GPU recommended

Related Skills

• ctDNA_Dynamics_MRD_Agent - Longitudinal MRD tracking
• Liquid_Biopsy_Analytics_Agent - Comprehensive liquid biopsy
• CHIP_Clonal_Hematopoiesis_Agent - CHIP filtering
• Tumor_Heterogeneity_Agent - Clonal tracking

Quality Control Metrics

| Metric | Threshold | Interpretation |

|--------|-----------|----------------|

| Mean Coverage | >30,000x | Sensitivity adequate |

| Duplex Rate | >20% | Error suppression possible |

| cfDNA Input | >30ng | Sufficient material |

| Tumor Mutations Tracked | >10 | Robust detection |

| Background Noise | <0.001% | Specificity maintained |

Special Considerations

1. Sample Quality: Requires high-quality cfDNA extraction
2. Sequencing Depth: Deep sequencing essential for sensitivity
3. CHIP Exclusion: Must filter clonal hematopoiesis variants
4. Tumor Heterogeneity: Track clonal and subclonal mutations
5. Timing: Sample >2 weeks post-surgery for clearance

Clinical Decision Support

| MRD-EDGE Result | Recommended Action |

|-----------------|-------------------|

| MRD+ (high confidence) | Consider adjuvant therapy |

| MRD+ (low confidence) | Repeat testing in 4-6 weeks |

| MRD- (high confidence) | Surveillance per guidelines |

| MRD- (low confidence) | Consider repeat testing |

Author

AI Group - Biomedical AI Platform

<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->